Table 1 Demographic and clinical characteristics of the three study groups.
NM-NC | GBA NM-MC | LRRK2 NM-MC | p-value | |
|---|---|---|---|---|
Age | 53.55 ± 10.51 | 52.85 ± 8.81 | 50.52 ± 7.56 | 0.44a |
Gender (F/M) | 18/16 | 12/14 | 13/12 | 0.91b |
Handedness | ||||
⁃ Right/left/ambidextrous | 29/4/2 | 25/1/0 | 20/4/1 | 0.19c |
UPDRS-III | 0.87 ± 1.26 | 0.61 ± 1.1 | 0.76 ± 2.05 | 0.86a |
UPDRS- Total | 6.62 ± 5.32 | 4.50 ± 2.8 | 5.96 ± 5 | 0.26a |
MOCA | 26.50 ± 2.68 | 26.69 ± 2.56 | 27.68 ± 2.68 | 0.28a |
UPSIT | 31.39 ± 6.95 | 30.35 ± 7.42 | 37.12 ± 9.11 | 0.66a |
BDI | 2.67 ± 6.21 | 5.28 ± 5.60 | 4.56 ± 4.77 | 0.08a |
SCOPA -AUT | 7.03 ± 6.21 | 6.52 ± 7.00 | 7.18 ± 6.22 | 0.93a |
RBDq | 2.00 ± 1.52 | 1.56 ± 2 | 1.43 ± 1.85 | 0.44a |
NMS | 3.18 ± 3.20 | 2.80 ± 3.24 | 2.95 ± 1.92 | 0.88a |
LR | 6.33 ± 17.00 | 11.38 ± 26.23 | 12.00 ± 26.00 | 0.57a |
⁃ Low (<70) [N, %] | 34, 97% | 24, 92% | 23, 92% | – |
⁃ High (>70) [N,%] | 1, 3% | 2, 8% | 2, 8% | – |